Advertisement
Advertisement

SRTA

S

Strata Critical Medical, Inc. Class A Common Stock

5.04
USD
Sponsored
+0.06
+1.21%
Jan 27, 15:59 UTC -5
Closed
exchange

Pre-Market

5.22

+0.18
+3.65%

SRTA Earnings Reports

Positive Surprise Ratio

SRTA beat 8 of 15 last estimates.

53%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
$61.56M
/
-$0.02
Implied change from Q3 25 (Revenue/ EPS)
+24.87%
/
-60.00%
Implied change from Q4 24 (Revenue/ EPS)
+13.25%
/
-84.62%

Strata Critical Medical, Inc. Class A Common Stock earnings per share and revenue

On Nov 10, 2025, SRTA reported earnings of -0.05 USD per share (EPS) for Q3 25, missing the estimate of -0.02 USD, resulting in a -96.08% surprise. Revenue reached 49.30 million, compared to an expected 44.88 million, with a 9.84% difference. The market reacted with a +9.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 61.56 million USD, implying an decrease of -60.00% EPS, and increase of 24.87% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.52
Actual
$8.01
Surprise
+6.44%
FAQ
For Q3 2025, Strata Critical Medical, Inc. Class A Common Stock reported EPS of -$0.05, missing estimates by -96.08%, and revenue of $49.30M, 9.84% above expectations.
The stock price moved up 9.48%, changed from $4.43 before the earnings release to $4.85 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 4 analysts, Strata Critical Medical, Inc. Class A Common Stock is expected to report EPS of -$0.02 and revenue of $61.56M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement